Company Filing History:
6 out of 37 
1 out of 1 Years Active: 1993-1998
Title: Anil Singhal: Innovator in Monoclonal Antibodies and Vaccine Development
Introduction
Anil Singhal, an accomplished inventor based in Seattle, WA, has made significant contributions to the fields of monoclonal antibodies and vaccine development. With a total of six patents to his name, Singhal has been at the forefront of innovative research aimed at combating cancer and improving immunization methods.
Latest Patents
Singhal's latest patents focus on the development of monoclonal antibodies and vaccines directed against human cancer-associated mucin-type glycoprotein antigens. His method entails a systematic approach, which includes immunizing a host with a core structure of a mucin-type glycoprotein, fusing splenocytes from the host with myeloma cells to form hybridoma cells, and culturing these cells on a selective medium. The process continues with the selection of hybridoma cells that secrete antibodies binding to the mucin-type glycoprotein and involves cloning and recovering these antibodies.
Additionally, Singhal's vaccine aims to prevent the growth and replication of cancer cells expressing mucin-type glycoproteins. The vaccine comprises a pharmaceutically effective amount of either a purified mucin-type glycoprotein or its chemical derivative, conjugated with a carrier peptide. Furthermore, he has developed a medicament for treating cancer where the cells express mucin-type glycoproteins, composed of an anti-cancer antibody and a pharmaceutically acceptable carrier.
Career Highlights
Throughout his career, Anil Singhal has been associated with notable institutions such as The Biomembrane Institute and Jichi Medical School. His innovative work has positioned him as a key player in the scientific community, contributing significantly to advancements in cancer treatment.
Collaborations
Singhal has worked alongside distinguished individuals such as Henrik Clausen and Sen-Itiroh Hakomori, whose collaborations have facilitated the development of his groundbreaking research.
Conclusion
Anil Singhal's dedication to innovation in the fields of monoclonal antibodies and vaccines exemplifies his commitment to finding solutions for cancer treatment. With his ongoing research and a solid patent portfolio, he continues to pave the way for advancements that could greatly benefit public health and medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.